The transistor technology developer has disclosed $21.8m in series A funding from investors including Agilent Technologies across three tranches.

American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.

Weber has bought the smart oven producer, one of its portfolio companies, in a deal that allows Amazon Alexa Fund to exit.

Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.

Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.

Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.

GV helped longtime portfolio company and database platform developer Cockroach Labs take its total funding to $355m at a $2bn valuation.

Monogenic disease therapy developer Lexeo Therapeutics has publicly launched with financing from backers including Lundbeckfonden Ventures.

Mitsui, Edison Energy, BMW, Daimler, General Motors and Exelon-backed electric bus manufacturer Proterra achieved a $1.6bn enterprise value in the deal.

TDK Ventures has exited the laser light source technology producer a year after an investment of undisclosed size.